• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
11.1% 0.4¢

ALTERITY THERAPEUTICS LIMITED

Market Cap $21.28M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
2 3
20:06 163 40K
20:06 Last post  Scottsmyname Comments Created with Sketch.  163  Views Created with Sketch.  40K 
ATH
Ann: Alterity Therapeutics to Present at MST Financial Webinar 		25/07/24 3 955
25/07/24 Last post  Scottsmyname Comments Created with Sketch.  3  Views Created with Sketch.  955 
ATH
Good to look at the reference study by Wenning et al 		24/07/24 4 1.3K
24/07/24 Last post  Mateo335 Comments Created with Sketch.  4  Views Created with Sketch.  1.3K 
ATH
Ann: Notice Under Section 708A 		20/07/24 2 987
20/07/24 Last post  Gordon2020 Comments Created with Sketch.  2  Views Created with Sketch.  987 
ATH
Value of company post Positive phase 2 trial results 		20/07/24 5 1.9K
20/07/24 Last post  Gordon2020 Comments Created with Sketch.  5  Views Created with Sketch.  1.9K 
ATH
Ann: Application for quotation of securities - ATH 		19/07/24 0 263
19/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  263 
ATH
Ann: Proposed issue of securities - ATH 		18/07/24 1 658
18/07/24 Last post  pivalde Comments Created with Sketch.  1  Views Created with Sketch.  658 
ATH
Ann: Trading Halt
2
17/07/24 75 22K
17/07/24 Last post  Scottsmyname Comments Created with Sketch.  75  Views Created with Sketch.  22K 

See All Discussions arrow Created with Sketch.

Timeline

Alterity Therapeutics to Present at MST Financial Webinar
24 Jul 11:15
 
Notice Under Section 708A
19 Jul 12:19
 
Application for quotation of securities - ATH
19 Jul 12:17
 
Proposed issue of securities - ATH
18 Jul 12:16
 
Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
17 Jul 10:20
 
Trading Halt
15 Jul 09:25
 
View More arrow Created with Sketch.

Featured News

NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
(20min delay)
Last
0.4¢ 		Change
-0.001(11.1%) 		Mkt cap ! $21.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $1.528K 317.5K

Buyers (Bids)

No. Vol. Price($)
102 97511267 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31179254 15
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
Last
0.4¢ 		  Change
-0.001 ( 11.1 %)
Open High Low Volume
0.5¢ 0.5¢ 0.4¢ 120006
Last updated 15.02pm 26/07/2024 ?
ATH (ASX) Chart

Top Stories

ASX Market Open: ASX200 to rise for Friday session | July 26

The ASX200 is set to rise 0.4% according to ASX futures around 8.30am on the final day of the week.
MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned MinRes (ASX:MIN) shares jumped 5% nearly right out the gate on Friday following an update from the miner it’s on track to meet FY24 production guidance.The already $50+ stock jumped 5%, perhaps surprising, if a cynic wanted to bring iron ore prices into it. The steelmaking commodi...
Capital raisings wrap: Brainchip, Ovanti, Lake and VHM Tech sector companies Ovanti Ltd and Brainchip Holdings Ltd joined Lake Resources Ltd and VHM Ltd in capital raising efforts.
Tissue Repairs soars nearly 32% on TGA approval for wound healing gel Biotech company Tissue Repair Ltd (ASX:TRP) has seen its share price rise more than 30% on news it had gained TGA (Therapeutic Goods Administration) approval for its advanced wound healing gel TR Pro+, which contains yeast-derived active ingredient Glucoprime.At 13:25 AEDT, shares in Tissue Repai...
Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit Red Hawk Mining (ASX:RHK) has announced an upgrade for the mineral resource incorporating the company’s Eagle Deposit.@Red Hawk is pleased to announce an MRE for Direct Shipping Ore (DSO) for the Eagle deposit at the 100%- owned Blacksmith Iron Ore Project of 71.1Mt at 57.4% Fe,&C...

Featured News

MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.